This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mammography World Markets

Figure A7.1: Estimates of National Expenditures for Cancer Care in 2010 by Site 201

Figure A7.2: National Expenditure for Cancer Care in 2010 by Site and Phase of Care 202

Figure A7.3: Proportion of National Expenditure for Cancer Care in 2010 by Site and Phase of Care 203

Figure A7.4: Percentage of Medicare Payments in the First Year Following Diagnosis for Cancer Care by Type of Service in 2002 204

Figure A9.1: Workflow Using Philips' iSite Radiology for Mammography SCR 210

Figure A9.2: Workflow Using Third Party Workstation for Mammography SCR 211


Table 3.1: The Top 50 Countries with Leading Breast Cancer Rates 24

Table 3.2: Estimated New Female Breast Cancer Cases and Death by Age in the U.S., 2011 25

Table 3.3: Probability of U.S. Women fore Being Diagnosed with Breast Cancer 25

Table 3.4: Female Breast Cancer Incidence and Mortality Rates by Race, Ethnicity and State 28

Table 3.5: Five-Year Cause-Specific Survival Rate by Race/Ethnicity 38

Table 3.6: New Breast Cancer Cases Diagnosed in Canadian Women, 2012 39

Table 3.7: New Breast Cancer Cases Diagnosed in Canada by Age Group, 2012 39

Table 3.8: Breast Cancer Mortality Rates in Canada, 2012 40

Table 3.9: Breast Cancer Incidence Rates per 100,000 Populations in the U.K., 2009 43

Table 3.10: Number of Breast Cancer Patients in the U.K., 2009-2010 43

Table 3.11: The Five Most Commonly Diagnosed Cancers, Females, Australia, 2008 47

Table 3.12: Risk and Average Age at Diagnosis of Female Breast Cancer in Australia, 1982-2008 50

Table 3.13: Incidence and Average Age at diagnosis by Type of Breast Cancer in Australia, 2008 51

Table 3.14: Incidence by Histological Type and Age at Diagnosis in Australia, 2008 51

Table 3.15: Incidence of Breast Cancer by Anatomical Location in Australia, 2008 52

Table 3.16: Relative Survival from Female Breast Cancer in Australia, 2006-2010 55

Table 3.17: Hospitalization for Female Breast Cancer in Australia, 2009-2010 55

Table 3.18: Breast Cancer in Asian Younger Women 59

12 of 14

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.64 0.00%
FB $118.57 0.00%
GOOG $698.21 0.00%
TSLA $241.80 0.00%
YHOO $36.53 0.00%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs